不孕与死亡
该研究为一项多中心随机临床试验的二次分析,纳入1992至2001年前瞻性入组的75784名55-74岁女性,随访至少10年(856935人年),采用疾病风险评分校正的Cox比例风险回归分析不孕史与全因及特定原因死亡的关系。结果显示不孕女性全因死亡风险增加10%(校正HR 1.10,95%CI 1.02-1.18,P=.010),癌症死亡风险增加23%(校正HR 1.23,95%CI 1.10-1.37,P<.001)。作者认为不孕是未来疾病和死亡的预兆。
要点
- 不孕女性全因死亡风险较无不孕史者增加10%(校正HR 1.10,95%CI 1.02-1.18,P=.010)。
- 不孕女性癌症死亡风险较无不孕史者增加23%(校正HR 1.23,95%CI 1.10-1.37,P<.001)。
- 在乳腺癌死亡风险 otherwise 低的女性中,不孕者乳腺癌死亡风险为无不孕史者的2.64倍(校正HR 2.64,95%CI 1.71-4.08,P<.001)。
核心结论
- 不孕是未来疾病和死亡的预兆,不孕女性全因死亡和癌症相关死亡风险增加。
研究设计与样本
- 该研究为多中心随机临床试验的二次分析,纳入1992至2001年前瞻性入组于前列腺、肺、结直肠和卵巢癌筛查试验的75784名55-74岁女性,随访至少10年(856935人年),采用疾病风险评分校正的Cox比例风险回归模型分析不孕史(尝试受孕1年或以上未孕)与全因及特定原因死亡的关系。
主要发现
- 不孕女性研究期间全因死亡风险较无不孕史者增加10%(校正HR 1.10,95%CI 1.02-1.18,P=.010)。
- 该效应主要见于其他方面死亡风险低的女性,其死亡风险增加26%(校正HR 1.26,95%CI 1.12-1.42,P<.001)。
- 心血管或糖尿病死亡风险无差异。
- 不孕女性研究期间任何时间癌症死亡风险较无不孕史者增加23%(校正HR 1.23,95%CI 1.10-1.37,P<.001)。
- 该效应主要见于其他方面癌症死亡风险低的女性,其癌症死亡风险增加47%(校正HR 1.47,95%CI 1.25-1.73,P<.001);子宫内膜癌或卵巢癌死亡风险无差异,而乳腺癌死亡风险 otherwise 低的女性中,不孕者乳腺癌死亡风险为无不孕史者的2.64倍(校正HR 2.64,95%CI 1.71-4.08,P<.001)。
临床怎么用
- 作者认为,在健康维护中考虑不孕史为长期健康结局的筛查和早期干预提供了机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Infertility affects 1 in 10 American reproductive-age women. The impact of this disease beyond the reproductive years is largely unknown. OBJECTIVE: The objective of the study was to determine the association of infertility history with all-cause and cause-specific mortality. STUDY DESIGN: This secondary analysis of a multicenter randomized clinical trial included 75,784 women (aged 55-74 years) prospectively enrolled in the Prostate, Lung, Colorectal, and Ovarian cancer-screening trial from 1992 through 2001 and followed up a minimum of 10 years for health-related outcomes and death (856,935 person-years). We examined the association of infertility history (inability to conceive for 1 year or greater) of all-cause and cause-specific mortality using disease risk score-adjusted Cox-proportional hazard regression models. RESULTS: Infertile women had a 10% increased risk of death (from any cause) during the study period compared with the unexposed (adjusted hazard risk, 1.10, 95% confidence interval, 1.02-1.18, P = .010). This effect was predominantly noted in women at an otherwise low risk of mortality who had a 26% increased risk of death (adjusted hazard risk, 1.26, 95% confidence interval, 1.12-1.42, P < .001). No differences in cardiovascular or diabetic mortality were noted. The risk of cancer death at any time over the study period was increased by 23% in infertile women compared with the unexposed (adjusted hazard risk, 1.23, 95% confidence interval, 1.10-1.37, P < .001). This effect was predominantly noted in women at an otherwise low risk of cancer mortality who had a 47% increased risk of cancer death (adjusted hazard risk, 1.47, 95% confidence interval, 1.25-1.73, P < .001). While no differences are seen in the risk of death from endometrial or ovarian cancer, the risk of death from breast cancer was more than doubled in infertile women at an otherwise low risk of breast cancer death compared with the unexposed (adjusted hazard risk, 2.64, 95% confidence interval, 1.71-4.08, P < .001). CONCLUSION: Infertility is a harbinger of future morbidity and mortality. Infertile women are at an increased risk of all-cause and cancer-related mortality. Consideration of infertility history in health care maintenance presents an opportunity for screening and early intervention for long-term health outcomes.
引用
- Stentz NC, Koelper N, Barnhart KT, et al. Infertility and mortality. Am J Obstet Gynecol. 2019. PMID: 31526792. doi:10.1016/j.ajog.2019.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。